Manulife (Manufacturers Life Insurance)’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.3M | Sell |
|
|||||
|
2025
Q1 | $26.7M | Sell |
|
|||||
|
2024
Q4 | $25.7M | Sell |
|
|||||
|
2024
Q3 | $52.6M | Sell |
|
|||||
|
2024
Q2 | $80M | Sell |
|
|||||
|
2024
Q1 | $50.4M | Sell |
|
|||||
|
2023
Q4 | $65.2M | Sell |
|
|||||
|
2023
Q3 | $63M | Buy |
|
|||||
|
2023
Q2 | $62M | Sell |
|
|||||
|
2023
Q1 | $67.6M | Sell |
|
|||||
|
2022
Q4 | $81.6M | Sell |
|
|||||
|
2022
Q3 | $183M | Sell |
|
|||||
|
2022
Q2 | $241M | Sell |
|
|||||
|
2022
Q1 | $286M | Buy |
|
|||||
|
2021
Q4 | $289K | Sell |
|
|||||
|
2021
Q3 | $327M | Sell |
|
|||||
|
2021
Q2 | $298M | Buy |
|
|||||
|
2021
Q1 | $227M | Buy |
|
|||||
|
2020
Q4 | $190M | Buy |
|
|||||
|
2020
Q3 | $169M | Sell |
|
|||||
|
2020
Q2 | $181M | Sell |
|
|||||
|
2020
Q1 | $139M | Buy |
|
|||||
|
2019
Q4 | $26.2M | Sell |
|
|||||
|
2019
Q3 | $19M | Sell |
|
|||||
|
2019
Q2 | $17.4M | Buy |
|
|||||
|
2019
Q1 | $19.5M | Sell |
|
|||||
|
2018
Q4 | $15.6M | Buy |
|
|||||
|
2018
Q3 | $18.6M | Buy |
|
|||||
|
2018
Q2 | $317K | Sell |
|
|||||
|
2018
Q1 | $386K | Buy |
|
|||||
|
2017
Q4 | $402K | Buy |
|
|||||
|
2017
Q3 | $332K | Buy |
|
|||||
|
2017
Q2 | $203K | Buy |
|
|||||
|
2017
Q1 | $122K | Hold |
|
|||||
|
2016
Q4 | $89K | Sell |
|
|||||
|
2016
Q3 | $199K | Hold |
|
|||||
|
2016
Q2 | $163K | Buy |
|
|||||
|
2016
Q1 | $171K | Buy |
|
|||||
|
2015
Q4 | $267 | Hold |
|
|||||
|
2015
Q3 | $228 | Buy |
|
|||||
|
2015
Q2 | $336 | Buy |
|
|||||
|
2015
Q1 | $227 | Hold |
|
|||||
|
2014
Q4 | $211 | Sell |
|
|||||
|
2014
Q3 | $2.32K | Sell |
|
|||||
|
2014
Q2 | $2.44M | Sell |
|
|||||
|
2014
Q1 | $10.4K | Sell |
|
|||||
|
2013
Q4 | $9.98K | Buy |
|
|||||
|
2013
Q3 | $9.63K | Buy |
|
|||||
|
2013
Q2 | $1.39M | Buy |
|